Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Post-traumatic Stress Disorder (PTSD)

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    29 result(s) found for: Post-traumatic Stress Disorder (PTSD). Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2021-003154-23 Sponsor Protocol Number: 1402-0030 Start Date*: 2022-04-05
    Sponsor Name:Boehringer Ingelheim AB
    Full Title: A Phase II, 8-week-treatment, multicenter, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy, tolerability and safety of orally administered BI 1358894 in ...
    Medical condition: Post-Traumatic Stress Disorder (PTSD)
    Disease: Version SOC Term Classification Code Term Level
    21.1 10037175 - Psychiatric disorders 10036316 Post-traumatic stress disorder PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed) FI (Completed) PL (Completed) HR (Completed)
    Trial results: View results
    EudraCT Number: 2012-003072-39 Sponsor Protocol Number: 41223 Start Date*: 2012-11-27
    Sponsor Name:Academic Medical Center, University of Amsterdam
    Full Title: Oxytocin in PTSD: effectiveness as addition to Narrative Exposure Therapy
    Medical condition: Posttraumatic stress disorder
    Disease: Version SOC Term Classification Code Term Level
    14.1 10037175 - Psychiatric disorders 10036316 Post-traumatic stress disorder PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-001878-29 Sponsor Protocol Number: 35RC18_8852_PROPRADO Start Date*: 2021-05-21
    Sponsor Name:Rennes University Hospital
    Full Title: The efficacy of traumatic memory modification using a memory reconsolidation procedure under propranolol among adolescents with post-traumatic stress disorder (PROPRADO)
    Medical condition: post-traumatic stress disorder
    Disease: Version SOC Term Classification Code Term Level
    21.1 10037175 - Psychiatric disorders 10036316 Post-traumatic stress disorder PT
    Population Age: Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-004982-41 Sponsor Protocol Number: 14865A Start Date*: 2013-11-11
    Sponsor Name:H. Lundbeck A/S
    Full Title: Interventional, randomised, double-blind, parallel-group, placebo-controlled, flexible-dose study of brexpiprazole as adjunctive treatment to paroxetine or sertraline in adult patients suffering...
    Medical condition: Post-traumatic stress disorder (PTSD)
    Disease: Version SOC Term Classification Code Term Level
    18.0 10037175 - Psychiatric disorders 10036316 Post-traumatic stress disorder PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: EE (Prematurely Ended) IT (Prematurely Ended) FI (Prematurely Ended) SE (Prematurely Ended) PL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2012-001288-58 Sponsor Protocol Number: 40122 Start Date*: 2012-05-21
    Sponsor Name:Academic Medical Center
    Full Title: Boosting oxytocin after trauma: The effects of intranasal oxytocin administration on emotional and motivational brain processes in PTSD
    Medical condition: Posttraumatic Stress Disorder (PTSD) according to criteria in the DSM-IV
    Disease: Version SOC Term Classification Code Term Level
    14.1 10037175 - Psychiatric disorders 10036316 Post-traumatic stress disorder PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: View results
    EudraCT Number: 2011-006228-19 Sponsor Protocol Number: PTF3 Start Date*: 2012-03-21
    Sponsor Name:Psykiatrisk Center Ballerup
    Full Title: The treatment of traumatized refugees with Setraline versus Venlafaxine - a randomized trial.
    Medical condition: Post traumatic stress disorder (PTSD) Depression
    Disease: Version SOC Term Classification Code Term Level
    17.0 10037175 - Psychiatric disorders 10036316 Post-traumatic stress disorder PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2015-004153-40 Sponsor Protocol Number: PTF5 Start Date*: 2016-01-07
    Sponsor Name:Competence Centre for Transcultural Psychiatry
    Full Title: TREATMENT OF SLEEP DISTURBANCES IN TRAUMA-AFFECTED REFUGEES – A RANDOMISED CONTROLLED TRIAL
    Medical condition: Posttraumatic Stress Disorder (PTSD)
    Disease: Version SOC Term Classification Code Term Level
    18.1 10037175 - Psychiatric disorders 10036316 Post-traumatic stress disorder PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2011-004177-83 Sponsor Protocol Number: 37202 Start Date*: 2011-11-14
    Sponsor Name:Academic Medical Center
    Full Title: Boosting the oxytocin system in acute trauma: The effectiveness of intranasal oxytocin treatments and stimulation of social support on preventing trauma related psychopathology
    Medical condition: Posttraumatic Stress Disorder (PTSD) according to criteria in the DSM-IV
    Disease: Version SOC Term Classification Code Term Level
    14.0 10037175 - Psychiatric disorders 10036316 Post-traumatic stress disorder PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-006714-15 Sponsor Protocol Number: PTF1 Start Date*: 2009-05-06
    Sponsor Name:Psykiatrisk Center Gentofte
    Full Title: The effect of treatment of traumatised refugees with Traume-Focused Cognitive Behavioural Therapy and antidepressants - a randomised controlled clinical trial.
    Medical condition: Posttraumatic Stress Disorder
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036316 Post-traumatic stress disorder LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-007068-27 Sponsor Protocol Number: 0604603 Start Date*: 2007-03-23
    Sponsor Name:CHU Toulouse
    Full Title: Réduction de la reconsolidation du souvenir traumatique par le propranolol : un essai pilote.
    Medical condition: Troubles du Stress Post-Traumatique (TSPT)
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036316 Post-traumatic stress disorder LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-006386-16 Sponsor Protocol Number: P060226 Start Date*: 2008-12-05
    Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
    Full Title: La reviviscence dans l'état de stress post-traumatique : une pathologie du rappel émotionnel ? Application thérapeutique
    Medical condition: La reviviscence dans l'Etat de Stress Post-Traumatique
    Disease: Version SOC Term Classification Code Term Level
    8.1 10036316 PT
    Population Age: Adults Gender: Male, Female
    Trial protocol: FR (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2020-003563-26 Sponsor Protocol Number: NL74799.018.20 Start Date*: 2020-10-15
    Sponsor Name:TNO
    Full Title: Reconsolidation: a new intervention for traumatized healthcare workers.
    Medical condition: Post-traumatic stress disorder.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2020-000934-16 Sponsor Protocol Number: Nl.060.44183 Start Date*: 2020-06-18
    Sponsor Name:TNO
    Full Title: Reconsolidation: a new intervention towards combat-related PTSD.
    Medical condition: Post-traumatic stress disorder.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2018-001718-13 Sponsor Protocol Number: MP18 Start Date*: 2019-10-18
    Sponsor Name:MAPS Europe B.V.
    Full Title: An Open- Label, Phase 2, Multicenter Feasibility Study if Manualized MDMA-Assisted Psychotherapy with an fMRI sub-study Assessing Changes in Brain Activity in Subjects with Posttraumatic Stress Dis...
    Medical condition: post-traumatic stress disorder (PTSD)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Completed) CZ (Completed) NO (Completed) DE (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2021-005596-39 Sponsor Protocol Number: MPELONG Start Date*: 2022-09-07
    Sponsor Name:MAPS Europe B.V.
    Full Title: Long-Term Safety and Persistence of Effectiveness of Manualized MDMA Assisted Therapy for the Treatment of Posttraumatic Stress Disorder
    Medical condition: post-traumatic stress disorder (PTSD)
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2020-005956-39 Sponsor Protocol Number: RC31/18/0471 Start Date*: 2021-04-06
    Sponsor Name:CHU Toulouse
    Full Title: Treatment of pediatric Post-traumatic Stress Disorder with memory reactivation under the influence of propranolol: A randomized placebo-controlled trial
    Medical condition: Post-traumatic Stress Disorder
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004873 10042211 Stress disorders HLT
    Population Age: Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2021-000312-36 Sponsor Protocol Number: PTSD-FMS Start Date*: 2021-05-19
    Sponsor Name:Henri Laborit Hospital
    Full Title: Impact of Post-Traumatic Stress Disorder Treatment by Reconsolidation Therapy on Fibromyalgia Syndrome
    Medical condition: Post-Traumatic Stress Disorder and fibromyalgia syndrome
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004873 10057246 Prolonged post-traumatic stress disorder LLT
    20.0 100000004859 10016631 Fibromyalgia syndrome LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2007-003891-20 Sponsor Protocol Number: NL17389.091.07 Start Date*: 2007-11-27
    Sponsor Name:GGZ Nijmegen
    Full Title: Een gerandomiseerde placebo gecontroleerde studie naar de toegevoegde waarde van D-cycloserine aan exposure therapie bij patiënten met een poststraumatische stress stoornis
    Medical condition: Posttraumatic stress disorder
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036876 Prolonged posttraumatic stress disorder LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-018486-37 Sponsor Protocol Number: dexa2010 Start Date*: 2010-05-21
    Sponsor Name:Kris-och Traumacentrum
    Full Title: Treatment of exacerbations of post-traumatic stress disorder by short-term dexamethasone, a pilot study.
    Medical condition: Posttraumatic stress syndrome F431
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-000030-39 Sponsor Protocol Number: na Start Date*: 2008-12-16
    Sponsor Name:Ministery of Defense, Military Mental Health - Research Centre
    Full Title: Prazosin as add-on therapy in the pharmacological treatment of sleep disturbances in post traumatic stress disorder, a placebo-controlled study using polysomnography
    Medical condition: posttraumatic stress disorder (PTSD)
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 01 06:20:10 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA